Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
56
-
Total shares
-
8.93M
-
Shares change
-
+1.61M
-
Total reported value, excl. options
-
$103M
-
Value change
-
+$18.9M
-
Put/Call ratio
-
1.41
-
Number of buys
-
38
-
Number of sells
-
-16
-
Price
-
$11.56
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q1 2015
60 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q1 2015.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.93M shares
.
Largest 10 shareholders include venBio Select Advisor LLC (2.21M shares), Cormorant Asset Management, LLC (1.65M shares), VANGUARD GROUP INC (588K shares), NUMERIC INVESTORS LLC (524K shares), MILLENNIUM MANAGEMENT LLC (473K shares), BlackRock Institutional Trust Company, N.A. (440K shares), BAIRD ROBERT W & CO INC /WI/ (284K shares), CAM Group Holding A/S (262K shares), MORGAN STANLEY (223K shares), and DEUTSCHE BANK AG\ (223K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.